Patents - stay tuned to the technology

Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


18th week of 2011 patent applcation highlights part 60
Patent application numberTitlePublished
20110105588COMPOSITIONS COMPRISING NOTCH1 SIRNA AND METHODS OF USE THEREOF - The present invention provides siRNA nucleic acid molecules that inhibit Notch1 expression. Methods of using the nucleic acid molecules are also provided.2011-05-05
20110105589APOPTOSIS INDUCER - This invention relates to an agent, a composition and a product comprising at least one apoptosis-inducing substance, and at least one substance which inhibits expression and/or activity of an apoptosis-inhibiting substance; a method for inducing apoptosis or for treating a proliferative disease using one or more of them; a nucleic acid construct comprising a nucleic acid molecule encoding a protein to be expressed and a nucleic acid molecule which inhibits expression of an undesired protein; and a method for expressing a desired protein in a cell while inhibiting the expression of an undesired protein.2011-05-05
20110105590Compositions And Methods For Inhibiting Expression Of Anti-Apoptotic Genes - The present invention relates to an isolated double-stranded ribonucleic acid (dsRNA) for inhibiting the expression of bcl-2, where the antisense strand comprises a sequence that comprises a region of complementarity which is substantially complementary to at least a part of an mRNA encoding bcl-2. The dsRNA, upon contact with a cell expressing the bcl-2, inhibits expression of the bcl-2 gene by at least 20%. The invention also relates to a pharmaceutical composition comprising the dsRNA together with a pharmaceutically acceptable carrier. The invention further relates to a vector for inhibiting expression of bcl-2 in a cell, where the vector comprises a regulatory sequence operably linked to a nucleotide sequence that encodes at least one strand of the dsRNA.2011-05-05
20110105591siRNA COMPOUNDS FOR INHIBITING NRF2 - The present invention provides chemically modified siRNA compounds that target the Nrf2 gene and pharmaceutical compositions comprising same useful for treating or preventing the incidence or severity of a cancerous disease, particularly various lung cancers.2011-05-05
20110105592ANTI-SENSE MICRORNA EXPRESSION VECTORS - The present invention relates to an alternative strategy for expressing the antisense sequence of a miRNA. This system allows for continuous production of the antisense sequence and subsequently complete knockdown of the targeted miRNA.2011-05-05
20110105593MicroRNA-Formatted Multitarget Interfering RNA Vector Constructs and Methods of Using The Same - Vectors expressing multiple microRNA (miRNA)-formatted interfering RNAs from a single transcript are disclosed and methods of using the same to inhibit expression of one or more target genes.2011-05-05
20110105594PALATABLE NUTRITIONAL COMPOSITION COMPRISING A NUCLEOTIDE AND/OR A NUCLEOSIDE AND A TASTE MASKING AGENT - The present invention relates to the use of a taste masking agent selected from the group of cellulose; starch; xanthan gum; gellan gum; alginate; galactomannans such as fenugreek, guar gum, tara gum, locust bean gum, and cassia gum; gum karaya; gum tragacanth; carrageenan; and mixture thereof, for improving one or more of mouth feel, taste, aftertaste and smell of a liquid aqueous nutritional composition comprising a nucleotide and/or a nucleoside. It also relates to a nutritional composition comprising an unsavoury nucleotide and/or a nucleoside component, having improved sensory characteristics such as improved mouth feel, taste, aftertaste and smell. In particular, it relates to a composition comprising said un-savoury nucleotide and/or a nucleoside component, in particular comprising an uridine-containing nucleotide and/or a nucleoside in combination with an unsavoury edible oil, such as a fish oil.2011-05-05
20110105595NOVEL PROMOTER AND VIRAL VECTOR CONTAINING THE SAME - The invention constructs an activating KRASmutant but not p53-responsive promoter and generates an E1B-55kD-deleted (ΔE1B-55kD) adenovirus, harboring a transcriptionally activating transgene and holding lytic replication ability in the tumor cells with activating KRAS2011-05-05
20110105596COMPOSITIONS AND METHODS FOR PROGNOSIS OF OVARIAN CANCER - Described herein are compositions and methods for the prediction of the prognosis of ovarian cancer subjects. The present invention further provides methods for distinguishing between histological subtypes of ovarian cancer tumors, and also methods and compositions for the treatment or prevention of ovarian cancer. Specifically the invention relates to microRNA molecules associated with said methods and compositions, as well as various nucleic acid molecules relating thereto or derived therefrom.2011-05-05
20110105597Modulation of pathogenicity - The present invention relates to the use of compounds of the general Formula (I):2011-05-05
20110105598Process for Preparation of Taxane Derivatives - The present disclosure relates to processes for the preparation of taxane derivatives with improved purity and enhanced stability. The taxane derivatives prepared according to the processes described herein are useful for the preparation of pharmaceutical compositions.2011-05-05
20110105599THERAPEUTIC OR PREVENTIVE AGENTS FOR ISCHEMIC NEUROPATHY - Therapeutic or preventive agents for ischemic nerve injury containing as the active ingredient compounds represented by the general formula [2]:2011-05-05
20110105600SYNERGISTIC COMPOSITION OF (-)-HYDROXYCITRIC ACID WITH MONOTERPENE AND A METHOD TO ENHANCE SATIETY - The present disclosure provides synergistic composition comprising (−)-hydroxycitric acid, its salts, amides and esters in conjunction with monoterpenes for enhancing satiety. The disclosure is also related to the use of synergistic composition in food and pharmaceutical compositions. The present disclosure helps in controlling obesity by enhancing satiety.2011-05-05
20110105601COMPOSITIONS FOR USE IN TREATING OR PREVENTING METABOLIC STRESS-INDUCED LUNG INJURY AND METHODS FOR INCREASING PHYSICAL CAPACITY OF MAMMALIAN LIVESTOCK - The present invention relates to a composition comprising (i) choline and (ii) a compound selected from the group consisting of palmitate, vitamin C and vitamin E for use in treating or preventing metabolic stress-induced lung injury and a method for increasing physical capacity of mammalian livestock comprising administering to the mammalian livestock the above composition.2011-05-05
20110105602Mitochondrial Aldehyde Dehydrogenase-2 Modulators and Methods of Use Thereof - The present invention provides compounds that function as modulators of mitochondrial aldehyde dehydrogenase-2 (ALDH2) activity; and pharmaceutical compositions comprising the compounds. The present invention provides therapeutic methods involving administering a subject compound, or a subject pharmaceutical composition. The present invention further provides assays for identifying agonists of ALDH2. 2011-05-05
20110105603COMPOSITIONS AND METHODS FOR TREATING BETA-AMYLOID RELATED DISEASES - In alternative embodiments the invention provides compositions and methods for ameliorating diseases and conditions having a beta-amyloid component, including Alzheimer's disease (AD), Vascular Dementia (VD), dementia, pre-dementia, Cognitive Dysfunction Syndrome (CDS) and loss of cognition in humans and in non-human animal. In alternative embodiment the invention provides analogs of AB-007 and its acid form E64c (loxistatin), their preparation, and pharmaceutical compositions thereof and methods of making and using same. In alternative embodiments compositions of the invention are deuterated analogs of AB-007 (or E64d) and E64c (or loxistatin). In alternative embodiments compositions of the invention are metabolically blocked forms as compared to AB-007 and loxistatin. In alternative embodiments compositions of the invention are used to ameliorate (including treat, slow, reverse or prevent) a disease or condition which can be ameliorated by partial or complete inhibition of a cysteine protease, e.g., AD, VD, CDS. The invention also provides alternative dosage forms and formulations for AB-007 and loxistatin, and for compounds of this invention, which can be used e.g., to treat AD, VD and CDS, in humans and in non-human animals.2011-05-05
20110105604MOISTURIZING AND CLEANSING COMPOSITION - An enhanced cleansing and moisturizing composition that uses strong cationic surfactants and strong anionic surfactants to deposit more moisturizers onto a user's skin. The improved cleansing and moisturizing composition, generally includes a water-soluble strong cationic surfactant, a water-soluble strong anionic surfactant, a polymeric surfactant, and an aqueous carrier.2011-05-05
20110105605METHOD OF PREPARING A LATANOPROST OPHTHALMIC SOLUTION AND THE RESULTING SOLUTION - A method of solubilizing an analog active agent of the prostaglandin F2α, such as latanoprost, is described and a method of preparing an ophthalmic solution of the solubilized latanoprost for the treatment of distinct ocular ailments. This invention also refers to an ophthalmic aqueous solution resulting from the aforementioned method, which is characterized by its chemical stability at room temperature, its safety, and innocuousness and efficiency in the treatment of the patient. The new ophthalmic aqueous solution is distinguished because its pharmaceutical value is found in the handling of a vehicle of easy access that not only permits the solubility of latanoprost, but also promotes its chemical stability and a greater tolerance of the patient with its ophthalmic application for the treatment of the patient's ailment.2011-05-05
20110105606Compositions and methods affecting the signaling pathways of LRP receptors - The present invention relates to the field of therapeutic methods, compositions and uses thereof, that affect, directly or indirectly, the behavior of LRP receptors. These compositions and methods result in the treatment of inflammatory, immunological and metabolic conditions. More particularly, the methods and compositions of the invention are directed to the identification of small molecules, drugs and/or pharmacological agents that affect the Wnt pathway by affecting normal complex formation among various signaling receptors, the LRP5 and LRP6 receptor, and related ligands.2011-05-05
20110105607LIPOPHILIC DIESTERS OF CHELATING AGENT FOR INHIBITION OF ENZYME ACTIVITY - The present invention relates to the use of lipophilic diesters of the chelating agent 1,2-bis(2 aminophenoxy)ethane-N,N,N′,N′-tetraacetic acid (BAPTA) for inhibition of proteolytic activities of certain metalloproteinases, calpain and TACE2011-05-05
20110105608MODULATORS OF NUCLEAR RECEPTOR CO-REGULATORY PROTEIN BINDING - Disclosed are novel compounds and compositions for inhibition of androgen and estrogen receptor signaling, methods for inhibiting androgen signaling, methods for inhibiting estrogen signaling, methods for inhibiting the interaction between a co-regulatory protein and an androgen or estrogen receptor, and methods for treating cancer.2011-05-05
20110105609ALLEVIATING OXIDATIVE STRESS DISORDERS WITH PUFA DERIVATIVES - Some aspects of the invention provide for essential fatty acids which are substituted in specific positions to slow down oxidative damage by Reactive Oxygen Species (ROS), and to suppress the rate of consequent formation of reactive products, for the purpose of preventing or reducing the damage associated with oxidative stress associated diseases such as neurological diseases and age-related macular degeneration (AMD).2011-05-05
20110105610Phospholipase A2 Inhibitors and their Use in Treating Neurological Injury and Disease - Phospholipase A2011-05-05
20110105611USE OF MASLINIC ACID FOR THE TREATMENT OF PATHOLOGIES AND THEIR SYMPTOMS THROUGH THE INHIBITION OF COX-2 - The invention relates to the use of maslinic acid or natural, synthetic or semi-synthetic maslinic-rich mixtures or of a composition containing said acid for the treatment of pathological processes associated with COX-2 activation, intended, inter alia, for the symptomatic and/or regenerative treatment of arthrosis, rheumatoid arthritis, fibromyalgia, sciatica and other articular disorders that are difficult to diagnose. The invention also relates to the topical administration thereof.2011-05-05
20110105612METHOD AND COMPOSITION FOR LONG ACTING BACTERIAL SUPPRESSION ON SKIN - The present disclosure relates to methods and compositions for suppressing the growth of microorganisms on selected areas of the skin for an extended period of time, such as one hour, twenty four hours, seventy two hours, or longer. An area of the skin is selected for the suppression of the growth of microorganisms and a microorganism growth suppressing agent is topically applied to the selected area of the skin. The microorganism growth suppressing agent may be comprised in a pharmacologically acceptable vehicle such as an emulsion or soap. The microorganism growth suppressing agent comprises free conjugated fatty acid such as conjugated linoleic acid.2011-05-05
20110105613MOISTURE RESISTANT CONTAINER SYSTEMS FOR RAPIDLY BIOAVAILABLE DOSAGE FORMS - Provided are rapidly bioavailable solid oral dosage forms of acute pain medications, and moisture resistant packaging that enables the formulation of such rapidly bioavailable dosage forms.2011-05-05
20110105614High Concentration Baclofen Preparations - Stable aqueous solutions comprising concentrations of baclofen in the range of greater than 2.0 mg/mL up to about 10 mg/mL are disclosed. These solutions can be used as pharmaceuticals for parenteral or oral administration. The invention also provides methods of preparing said stable aqueous baclofen solutions.2011-05-05
20110105615TABLET QUICKLY DISINTEGRATING IN THE ORAL CAVITY AND METHOD FOR PRODUCING THE SAME - The present invention relates to a tablet which is rapidly disintegrated in an oral cavity containing an active ingredient at a high content and a production method thereof. That is, the present invention provides a tablet which is rapidly disintegrated in an oral cavity containing an active ingredient in not less than 25% of the total weight, having a disintegration time of within 40 seconds and an absolute hardness of 1.8 N/mm2011-05-05
20110105616NOVEL LYSINE SALTS OF 4-((PHENOXYALKYL)THIO)-PHENOXYACETIC ACID DERIVATIVES - The present invention is directed to a novel lysine salts, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by PPAR delta. The present invention is further directed to a novel process for the preparation of said lysine salts.2011-05-05
20110105617METHOD FOR TREATMENT OF NEOPLASTIC DISEASES WITH ALPHA-KETO GLUTARATE AND/OR SALTS THEREOF - A method for treatment or prophylaxis of neoplastic diseases includes administering an antineoplastic preparation to a subject in need thereof. The active component of the antineoplastic preparation is alpha-ketoglutarate and/or a salt of alpha-ketoglutarate.2011-05-05
20110105618NOVEL MODULATORS OF PROTEIN KINASE SIGNALING - The present invention provides new tyrphostin derivatives acting as protein kinase (PK) and receptor kinase (RK) signaling modulators. The invention further provides methods of their preparation, pharmaceutical compositions including such compounds, and methods of using these compounds and compositions, especially as chemotherapeutic agents for preventions and treatments of PK and RK related disorders such as metabolic, inflammatory, fibrotic, and cell proliferative disorders, in particular cancer.2011-05-05
20110105619AMORPHOUS BUPROPION HYDROBROMIDE AND PREPARATION THEREOF - The present invention provides an amorphous bupropion hydrobromide and an amorphous bupropion hydrobromide granulates with at least one pharmaceutically acceptable carrier, and a process for its preparation.2011-05-05
20110105620ORGANIC COMPOUNDS - A solid pharmaceutical composition suitable for oral administration, comprising: (a) S 1 P receptor agonist; and (b) a sugar alcohol.2011-05-05
20110105621METHOD OF REDUCING BRAIN CELL DAMAGE, INFLAMMATION OR DEATH - A method of reducing the occurrence of brain cell damage or death caused by transient cerebral hypoxia, ischemia, brain inflammation or a traumatic brain injury (TBI) event. The method typically comprises identifying a subject with transient cerebral hypoxia, ischemia, brain inflammation or a TBI, and within 24 hours of onset of the condition, administering to the subject a continuous intravenous infusion dose of methamphetamine in an amount sufficient to reduce the occurrence of brain cell damage or death caused by the condition. Preferably, the dose is increased in response to a delay in administration. The invention also relates to a method for modulating cytokine expression within the brain to treat such conditions.2011-05-05
20110105622PHARMACEUTICAL COMPOSITION CONTAINING GLUR2-LACKING AMPAR ANTAGONIST FOR PREVENTING OR TREATING PSYCHIATRIC ILLNESSES - A pharmaceutical composition, comprising a GluR2-lacking AMPAR antagonist as an active ingredient, is effective for preventing or treating mental diseases selected from the group consisting of posttraumatic stress disorder (PTSD), drug addiction, and phobia.2011-05-05
20110105623USE OF METHYLSULFONYLMETHANE (MSM) TO MODULATE MICROBIAL ACTIVITY - Disclosed herein are methods of use of methylsulfonylmethane (MSM) to modulate microbial activity, such as to enhance or inhibit the activity of microorganisms. In one example, MSM (such as about 0.5% to 5% MSM) is used to enhance fermentation efficiency, such as to enhance fermentation efficiency associated with the production of beer, cider, wine, a biofuel, dairy product or any combination thereof. Also disclosed are in vitro methods for enhancing the growth of one or more probiotic microorganisms and methods of enhancing growth of a microorganism in a diagnostic test sample. Methods of inhibiting microbial activity are also disclosed. In one particular example, a method of inhibiting microbial activity includes selecting a medium that is susceptible to H1N1 influenza contamination; and contacting the medium with MSM at a concentration of about 10% to about 16% of weight by volume, thereby inhibiting H1N1 influenza microbial activity.2011-05-05
20110105624ENDIPALENE FORMULATIONS IN THE TREATMENT OF PSORIASIS - The present invention relates to the field of molecules suitable for treatment of inflammation through inhibitory actions in one or more steps of the Arachidonic Acid pathway. Specifically the present invention provides an improvement in the use of Endipalene molecules as anti-inflammatory pharmaceutical agents, more specifically as 5-lipoxygenase inhibitor agents, for treating inflammation and inflammation-related skin disorders.2011-05-05
20110105625OPHTHALMIC COMPOSITION FOR CONTACT LENS - Disclosed are; a method for suppressing adsorption of a refreshing agent and/or chlorobutanol by a contact lens in an aqueous ophthalmic composition for contact lens containing a refreshing agent and/or chlorobutanol, as well as for suppressing pH decline due to degradation of chlorobutanol, wherein the method comprises preparing the composition in the form of an oil-in-water type emulsion. An ophthalmic composition for contact lens in the form of an oil-in-water type emulsion containing a refreshing agent and/or chlorobutanol is also disclosed.2011-05-05
20110105626USE OF CYCLOHEXANEHEXOL DERIVATIVES FOR THE TREATMENT OF POLYGLUTAMINE DISEASES - The present invention relates to methods to modulate the assembly, folding, accumulation, rate of aggregation, oligomerization or clearance of proteins or fragments comprising PoIyQ, by using compositions comprising cyclohexanehexol derivatives. More specifically, the invention provides a medicament comprising cyclohexanehexol derivatives of formula III or formula IV, more particularly a scyllo-inositol compound, analog or derivative thereof, useful in the treatment of polyglutamine diseases, such as Huntington's disease and related neurodegenerative disorders including dentatorubral pallidoluysian atrophy, spinal and bulbar muscular atrophy and spinocerebellar ataxia type 1, 2, 3, 6, 7 and 17.2011-05-05
20110105627METHOD OF CONTROLLING OIL-ABSORBING PROPERTIES OF A SILICONE RUBBER POWDER - A method of controlling oil-absorbing properties of a silicone rubber powder characterized by keeping a silicone rubber powder in hot storage at a temperature in the range of 40° C. to 150° C. or in cold storage at a temperature in the range of 0° C. to 10° C.2011-05-05
20110105628WATER-DISPERSIBLE AND MULTICOMPONENT FIBERS FROM SULFOPOLYESTERS - Disclosed are multicomponent fibers derived from a blend of a sulfopolyester with a water non-dispersible polymer wherein the as-spun denier is less than about 6 and wherein the water dispersible sulfopolyester exhibits a melt viscosity of less than 12,000 poise measured at 240° C. at a strain rate of 1 rad/sec, and wherein the sulfopolyester comprising less than about 25 mole % of residues of at least one sulfomonomer, based on the total moles of diacid or diol residues. The multicomponent fiber is capable of being drawn at a relatively high fiber speed, particularly at least about 2000 m/min, and may be used to produce microdenier fibers. Fibrous articles may be produced from the multicomponent fibers and microdenier fibers. Also disclosed is a process for multicomponent fibers, nonwoven fabrics, and microdenier webs.2011-05-05
20110105629PROCESS AND SYSTEM FOR REDUCING SIZES OF EMULSION DROPLETS AND EMULSIONS HAVING REDUCED DROPLET SIZES - A method of producing an emulsion includes preparing a droplet solution comprising first and second molecular species, the droplet solution being in a fluid phase, wherein the first molecular species is soluble in the second molecular species; forming a plurality of droplets from the droplet solution in a bulk fluid to create a first emulsion, the plurality of droplets having a first ensemble average radius in the bulk fluid, wherein the first molecular species of the droplet solution is at least partially soluble in the bulk fluid and the droplet solution is at least partially immiscible in the bulk fluid; and allowing molecules of the first molecular species to migrate from the plurality of fluid droplets to the bulk fluid due to a higher concentration of the first molecular species in the droplet solution than the bulk fluid to result in the plurality of droplets having a second ensemble average radius that is smaller than the first ensemble average radius. An emulsion includes a bulk fluid and a plurality of droplets dispersed in the bulk fluid. The plurality of droplets have an ensemble average radius less than about 25 nm and greater than about 5 nm.2011-05-05
20110105630Catalytic Support for use in Carbon Dioxide Hydrogenation Reactions - A catalyst support which may be used to support various catalysts for use in reactions for hydrogenation of carbon dioxide including a catalyst support material and an active material capable of catalyzing a reverse water-gas shift (RWGS) reaction associated with the catalyst support material. A catalyst for hydrogenation of carbon dioxide may be supported on the catalyst support. A method for making a catalyst for use in hydrogenation of carbon dioxide including application of an active material capable of catalyzing a reverse water-gas shift (RWGS) reaction to a catalyst support material, the coated catalyst support material is optionally calcined, and a catalyst for the hydrogenation of carbon dioxide is deposited on the coated catalyst support material. A process for hydrogenation of carbon dioxide and for making syngas comprising a hydrocarbon, esp. methane, reforming step and a RWGS step which employs the catalyst composition of the present invention and products thereof.2011-05-05
20110105631Hydrophilic Polymer Membranes - A hydrophilic polymeric ionomer obtainable by reacting, in a solvent, components comprising a polymer and an ionic component selected from a strong acid or a strong base. The present invention also comprises methods of forming such membranes.2011-05-05
20110105632METHOD AND SYSTEM FOR PROCESSING WASTE MATERIALS - Methods and systems for processing waste materials and for manufacturing composite materials are disclosed herein. According to some embodiments, the heterogeneous waste includes a plastic component and a non-plastic component, and the non-plastic component includes a plurality of pieces of waste. The heterogeneous waste is heated to melt at least a portion of said plastic component and reducing a volume of said heterogeneous waste, and then mixed (e.g. by rotating a mixing chamber or by stirring) until at least some said pieces are each encapsulated by the melted plastic component. Upon cooling, the mixture optionally sets into a composite material. The presently disclosed invention does not require pre-sorting of the heterogeneous waste and is operative to process “as is” waste. Optionally, the waste is pre-sorted. Exemplary uses for the composite material include but are not limited to flooring sheets, construction bricks, thermal insulation, acoustic walls, road paving materials, road beds, ballistic shields shock absorbing flooring, artificial islands, artificial reefs, and marine docks.2011-05-05
20110105633FUNCTIONALIZED STILBENE-POLYALKYLENE OXIDE PREPOLYMERS - Stilbene-polyalkylene oxide prepolymers which include a polyalkylene oxide backbone with two or more isocyanate substituents and at least one hydroxystilbene or methoxystilbene substituent are useful as one component adhesives and biocompatible device coatings. Stilbene-polyalkylene compositions useful as a two component adhesive contain: a) a polyalkylene oxide having two or more amine substituents with b) a stilbene polyisocyanate compound, or alternatively contain: a) a polyethylene oxide having two or more isocyanate substituents with b) a stilbene diamine compound, or, alternatively contain: a) a bioabsorbable group in addition to a stilbene group attached to a polyalkylene backbone and b) a diamine compound.2011-05-05
20110105634CATALYSIS OF VISCOELASTIC FOAMS WITH BISMUTH SALTS - The embodiments of the present invention provide for viscoelastic polyurethane foams made in the presence of a bismuth comprising catalyst. The viscoelastic polyurethane foam may be the reaction product of a reaction mixture including at least one polyol and at least one isocyanate, wherein the at least one polyol and the at least one isocyanate are reacted in the presence of at least one bismuth comprising catalyst, and wherein the viscoelastic polyurethane foam has a density of less than 100 kg/m2011-05-05
20110105635POLYURETHANE FOAM FOR USE IN MEDICAL IMPLANTS - The present invention provides a polyurethane implant that is porous and degradable, and act as a scaffold for the repair of damaged tissue. Importantly, the implant of the present invention is biocompatible with the degradation products of the implant causing minimal immune or cytotoxic reaction. The present invention also provides for a method of making these biocompatible implants.2011-05-05
20110105636ORGANIC AEROGEL, COMPOSITION FOR THE MANUFACTURE OF THE ORGANIC AEROGEL, AND METHOD OF MANUFACTURING THE ORGANIC AEROGEL - An organic aerogel including a polymer that is a reaction product of a substituted or unsubstituted alkyl cellulose compound or derivative thereof and a substituted or unsubstituted alkylene diphenyl diisocyanate compound, as well as a composition for the manufacture of an organic aerogel, and a method of manufacturing the organic aerogel.2011-05-05
20110105637ADHESIVE ENCAPSULATING COMPOSITION AND ELECTRONIC DEVICES MADE THEREWITH - Adhesive encapsulating compositions for use in electronic devices such as organic electroluminescent devices, touch screens, photovoltaic devices, and thin film transistors are disclosed herein. The adhesive encapsulating compositions include pressure sensitive adhesives comprising one or more polyisobutylene resins, in combination with optional multifunctional (meth)acrylate monomers and/or optional tackifiers.2011-05-05
20110105638POLYFUNCTIONAL VINYL AROMATIC COPOLYMER, PROCESS FOR PRODUCING THE SAME, AND RESIN COMPOSITION - An end-modified soluble polyfunctional vinyl aromatic copolymer, which is improved in heat resistance, thermal stability, solvent solubility, and compatibility with acrylate compounds, and a curable resin composition using the same are disclosed. The end-modified soluble polyfunctional vinyl aromatic copolymer is obtained by allowing a divinyl aromatic compound (a), a monovinyl aromatic compound (b), and an aromatic ether compound (c) to react with each other, and has, at an end, an end group derived from the aromatic ether compound and having an acrylate bond. The copolymer has a number average molecular weight Mn of 500 to 100,000, an introduction amount (c1) of the end group derived from the aromatic ether compound satisfies (c1)≧1.0 (group/molecule), a molar fraction a′ of a structural unit derived from the divinyl aromatic compound and a molar fraction b′ of a structural unit derived from the monovinyl aromatic compound in the copolymer satisfy 0.05≦a′/(a′+b′)≦0.95. Besides, the curable resin composition includes the copolymer and an unsaturated acrylate monomer.2011-05-05
20110105639OXYGEN-SCAVENGING MIXTURES - An oxygen-scavenging mixture comprising: (I) an oxidizable metal component; (II) an electrolyte component selected from the group consisting of KCl and CaCl2011-05-05
20110105640Bone cement having porous fiber reinforcement - The bone cement matrix consists of three base component parts, which when mixed form a radiopaque rapidly setting bone cement, namely, a powdered or granular low viscosity polymer component; a liquid reactive or polymerizable monomer component; and a reinforcement component consisting of porous ceramic fibers. The ceramic fibers are porous and have a rough outer surface created by the pores and cavity permeating the fibers. The pores, cavities and rough surface of the fibers themselves, provide the mechanical interface for securely bonding the fibers to the polymer component. During polymerization, the polymer component saturates into the pores and cavities of the ceramic fibers creating a positive interdigitation of the polymer and fibers within the cement matrix.2011-05-05
20110105641SOLVENT- FREE MOISTURE ACTIVATED LATENT CURING SURGICAL ADHESIVE OR SEALANT - The invention relates to a novel moisture activated solvent-free latent curing adhesive or sealant mixture comprising (1) a selected poly (alkylene oxide) imine, and (2) a selected amine reactive moiety.2011-05-05
20110105642Drag reducing agent and method of use - The present invention relates to a drag reducing agent, composition, compound, product, process and method of use for use in petroleum pipelines and the like. A preferred embodiment of the present invention provides a cryogenically-ground polyalphaolefin polymer at 15-25 wt. % of the commercial product formulation. The bulking agents comprise ethylene bis-stearamide alone or in combination with other polyethylene and/or polypropylene polymers at 2.0-5.0 wt. % of the commercial product formulation. In addition, diisobutyl ketone 20-60 wt. % of the commercial product formulation and propylene carbonate 2.8-8.4 wt. % of the commercial product formulation are used.2011-05-05
20110105643POLYMER-ENCAPSULATED NANOPARTICLES - A polymer-encapsulated nanoparticle is disclosed herein. The polymer-encapsulated colorant nanoparticle includes a colorant nanoparticle core, and a polymer coating permanently established on the colorant nanoparticle core via covalent bonding or physical bonding, the polymer coating including in situ polymerized monomers or prepolymers of a discontinuous phase of an inverse emulsion. The polymer-encapsulated colorant nanoparticle has a size ranging from about 20 nm to about 1000 nm.2011-05-05
20110105644TOUGHENED POLY(TRIMETHYLENE TEREPHTHALATE) MOLDING RESINS AND MOLDED ARTICLES THEREFROM - Poly(trimethylene terephthalate compositions comprising (a) molding resin comprising a poly(trimethylene terephthalate) resin and 0.1 to 4 weight percent of one or more ionomer polymers or a combination of the ionomer polymers and acid copolymers; (b) 0 to about 50 weight percent of one or more fillers, based on the total weight of the molding resin; and (c) about 1.0 to about 5 weight percent of one or more Group A polymeric tougheners based on the total weight of components (a) and (c);2011-05-05
20110105645MATTE CLEAR COAT ENAMEL AND SUBSTRATES COATED THEREWITH - The present invention relates to a clear coat enamel composition comprising: 2011-05-05
20110105646EPOXY RESIN COMPOSITION FOR ENCAPSULATING ELECTRONIC PART - An epoxy resin composition for encapsulating electronic parts is provided which contains an inorganic filler in a large amount and which has a low viscosity and is flowable at ordinary temperature. The composition reconciles reactivity and storage stability, is excellent in suitability for demolding, molded-object appearance, etc., and is reduced in warpage. The epoxy resin composition comprises: (A) 100 parts by weight of an epoxy resin, (B) 50 to 150 parts by weight of an acid anhydride, and (C) 8 to 40 parts by weight of a curing accelerator of the microcapsule-type which satisfies the following: when 10 parts by weight of the curing accelerator is mixed with 100 parts by weight of the epoxy resin (A) and 100 parts by weight of a methyltetrahydroxy acid anhydride as the acid anhydride (B), the mixture has a viscosity increase ratio through 24 hours standing at 25° C. of 1.0 to 2.0 times. The composition further contains (D) fused spherical silica having an average particle diameter of 20 to 40 μm in an amount of 88 to 92% by weight of the composition. The composition has a viscosity, as measured at 25° C. under a shear rate of 2.5 (1/s), of 1000 Pa·s or lower.2011-05-05
20110105647Countertop Coating - Two component coatings having a viscosity range of 6 to 9 wet mils of sag consisting of a base component and an activator component. The base component comprises an epoxy siloxane resin and an alkyl quaternary ammonium clay rheology agent, and the activator component is an amino silane.2011-05-05
20110105648PROCESS OF COPOLYMERIZATION IN EMULSION OF 1-ALKENES AND VINYL ESTERS WITH HIGH CONVERSION AND THEIR USE - New process conditions are described and more particularly emulsion polymerization of compositions which are based on copolymers of vinyl acetate, straight chain α-olefin and an optional third different olefinically-unsaturated co-monomer in which the α-olefin is emulsified prior to the addition into the polymerization mixture.2011-05-05
20110105649FIRE RETARDANT RESIN COMPOSITION - A disclosed fire retardant resin composition includes a thermoplastic resin and a fire retardant. The fire retardant is formed of phosphorated polysaccharide that is formed by attaching thiophosphoric acid ester or phosphoric acid ester to a side chain of natural polysaccharide.2011-05-05
20110105650METHOD AND SYSTEM FOR PREPARING DENSIFIED LIGNOCELLULOSIC PULP FOR USE IN THERMOPLASTIC COMPOSITE MANUFACTURING PROCESSES - A method of preparing lignocellulosic fibre aggregates from a densified mass of lignocellulosic fibre, such as densified bales, for use in manufacturing high performance, recyclable and moldable lignocellulosic fibre and thermoplastic composites, or articles made of the high performance, recyclable and moldable lignocellulosic fibre and thermoplastic composites is provided. The method includes: (a) feeding densified forms of lignocellulosic fibre into a size reduction device; and size reducing the lignocellulosic fibres so as to produce dense lignocellulosic fibre aggregates having an average size profile suitable for use in manufacturing high performance, recyclable and moldable lignocellulosic fibre and thermoplastic composites, or articles made of the high performance, recyclable and moldable lignocellulosic fibre and thermoplastic composites. The density of the lignocellulosic fibre is generally maintained throughout the method. A system for preparing lignocellulosic fibre in accordance with the method is also provided.2011-05-05
20110105651MODIFIED ASPHALT BINDERS AND ASPHALT PAVING COMPOSITIONS - A modified asphalt binder composition prepared by combining asphalt binder, phosphorus pentasulfide, and less than 2.5 parts by weight unsaturated polymer, per 100 parts by weight asphalt binder, to thereby produce a modified asphalt binder composition characterized by an elongation recovery at 25° C., as determined according to AASHTO T301, of greater than 75%, where the phosphorus pentasulfide includes a blend of P2011-05-05
20110105652MODIFIED ASPHALT BINDERS AND ASPHALT PAVING COMPOSITIONS - A modified asphalt binder composition prepared by combining asphalt binder, phosphorus pentasulfide, and less than 2.5 parts by weight unsaturated polymer, per 100 parts by weight asphalt binder, to thereby produce a modified asphalt binder composition characterized by an elongation recovery at 25° C., as determined according to AASHTO T301, of greater than 75%.2011-05-05
20110105653Metal Complexes Used as Driers in Coatings - The present invention relates to a coating that includes a film forming binder, a solvent, and a metal complex that functions as a drier. In some preferred embodiments, the metal complex is an aluminum compound, and more particularly an aluminum compound having certain preferred structures as disclosed herein.2011-05-05
20110105654Method for Producing a Compound with at Least One at Least Monosubstituted Amino Group - The invention relates to a method for producing a compound having at least one mono substituted amino group. According to the invention, a starting substance supporting at least one amino group as reacted with a reagent supporting a first functional group and at least one other functional group in a reaction mixture. The first functional group is a hydroxyl group and the at least one other functional group is selected from hydroxyl groups, mercapto groups, carboxylic acid groups, carboxylic acid ester groups, carboxylic acid amide groups, keto groups, carbonate groups, halogens, epoxy groups and carbamate groups. If several other functional groups are present, the groups are selected independently of one another from the aforementioned class. Melamine, urea and guanamine are, in particular, reacted with glycol, glycerine and hydroxyl acetic acid derivatives.2011-05-05
20110105655FILLED POLYAMIDE MOLDING MATERIALS - Filled polyamide molding compounds which, in addition to a selected polymer mixture comprising polyamides and a flameproofing agent, contain glass fibers with non-circular cross-sections, the use of such molding compounds for the production of molded articles, and the molded articles themselves.2011-05-05
20110105656COLLOIDAL CRYSTAL GEL, ITS PRODUCTION PROCESS, AND OPTICAL DEVICES USING THE SAME - The invention has for its object to provide a colloidal crystal gel with which any enclosure structure is dispensed with, its production process, and an optical device using the same.2011-05-05
20110105657POLYOLEFIN RESIN COMPOSITION - Disclosed is a polyolefin resin composition which has an excellent transparency even when the polyolefin resin has a high melt flow rate (MFR).2011-05-05
20110105658PHOSPHATE ESTER POLYMERIC MIXTURE CONTAINING INTERMEDIATE TRANSFER MEMBERS - An intermediate transfer media, such as a belt, that includes a phosphate ester and a polymeric binder.2011-05-05
20110105659POLYCARBONATE COMPOSITION WITH IMPROVED MELT-FLOWABILITY - The invention relates to a polycarbonate composition with improved melt-flowability together with good optical properties and together with good hydrolysis resistance.2011-05-05
20110105660PROCESS FOR THE HOMOGENEOUS INCORPORATION OF POLYMER PARTICLES INTO POLYMERIC MATRICES - The invention relates to preparations comprising a wax in which polymer particles are present, where the polymer particles comprise at least one effect substance, obtainable by, by means of a miniemulsion polymerization carried out in the presence of a wax-immiscible solvent, distributing at least one effect substance in polymer particles, and incorporating the polymer particle dispersion obtained in this way into a wax by phase transfer.2011-05-05
20110105661WATER-IN-OIL POLYMER EMULSIONS - Inverse emulsions have a discontinuous internal phase of an aqueous solution of water soluble polymer and a continuous external phase of a stabilised oil system of an oil and an oligomeric stabiliser including urethane and/or urea linkages and residues of a fatty acid dimer and/or trimer component. The stabiliser is particularly either dimer based with units of the formula (I): —(X)-(D)-(X)CO—NH—R2011-05-05
20110105662FLUORORESIN FILM FOR AGRICULTURAL USE - The present invention provides an agricultural fluororesin film having good optical transparency and good durability to repeated contact with other members and to repeated bending. The present invention relates to an agricultural fluororesin film, in which synthetic mica particles having an average particle size of 3 μm to 15 μm are dispersed in a film containing a fluororesin, in which the content of the synthetic mica particles is from 0.5 to 5 parts by mass based on 100 parts by mass of the fluororesin.2011-05-05
20110105663ORGANOSILICATE COMPOUND, AND COMPOSITION AND FILM INCLUDING THE SAME - Disclosed are an organosilicate compound represented by the following Chemical Formula 1, and a composition and a film including the same.2011-05-05
20110105664THERMOPLASTIC POLYMER COMPOSITION - A thermoplastic polymer composition comprises a thermoplastic polymer and a nucleating agent. The nucleating agent comprises a compound conforming to the structure of Formula (I) or Formula (II)2011-05-05
20110105665METHODS FOR IMPROVING PHYSICAL PROPERTIES OF POLYESTERS - Methods and compositions for improving certain physical properties of polyesters are provided. The compositions are based on poly(trimethylene ether)glycol, and can improve properties such as toughness and flexibility in polyesters, providing a balance of desired properties.2011-05-05
20110105666FINE PARTICLE DISPERSION LIQUID CONTAINING TANTALUM OXIDE FINE PARTICLES, TANTALUM OXIDE FINE PARTICLE-RESIN COMPOSITE, AND METHOD OF PRODUCING FINE PARTICLE DISPERSION LIQUID - Provided are fine particle dispersion liquid containing tantalum oxide fine particles each having a small crystallite size and uniformly dispersed in an organic solvent, a tantalum oxide fine particle-resin composite, and a method of producing the dispersion liquid. The method of producing a fine particle dispersion liquid containing tantalum oxide fine particles includes: preparing a mixture of the tantalum oxide fine particles, a basic compound, a surface modifier, and an organic solvent; and subjecting the mixture to a dispersion treatment.2011-05-05
20110105667POLYOLEFIN COMPOSITION - An inventive polyolefin material is provided that includes post-consumer recycled content. The material offers surprisingly superior melt flow characteristics and flame properties that improve handling and usefulness for formation of molded articles. The inventive material is optionally an alloy of polypropylene and high density polyethylene combined α-olefin copolymer and a filler.2011-05-05
20110105668RUBBER LAMINATE - Disclosed is a rubber laminate containing an unvulcanized fluororubber composition comprising: (A) fluororubber comprising a terpolymer containing 50 to 60 mol % of a constitutional unit derived from vinylidene fluoride, 20 to 30 mol % of a constitutional unit derived from tetrafluoroethylene, and 10 to 30 mol % of a constitutional unit derived from hexafluoropropene; (B) an oxide and/or hydroxide of a divalent metal; (C) a polyhydroxy aromatic compound; (D) a 2-substituted-4,6-dithiol-s-triazine derivative; (E2011-05-05
20110105669PROCESS OF FORMING VULCANIZABLE ELASTOMERIC COMPOSITIONS USING ULTRA ACCELERATORS AND PRODUCTS FORMED THEREFROM - A vulcanizable elastomeric composition and a method of forming said composition is presented. The method generally comprises the mixing of sulfur and an ultra-accelerator into a mixture of an elastomeric polymer matrix, fillers, and silane coupling agent during the silanization reaction step, prior to the occurrence of vulcanization. The addition of the ultra-accelerator, such as TBzTD, enhances the efficiency of the silanization reaction and forms at least one bond with the elastomeric polymer matrix. The silanization reaction step may comprise multiple mixing substeps in which the ultra-accelerator may be incorporated into the elastomeric composition.2011-05-05
20110105670PROCEDURE FOR MANUFACTURE OF AQUEOUS SUSPENSIONS OF CALCIUM CARBONATE AND SUSPENSIONS OBTAINED, AND THEIR USES - The object of the invention consists of a process for the manufacture of aqueous suspensions of calcium carbonate using an acrylic polymer with an average by weight molecular weight of between 8,000 g/mole and 15,000 g/mole and a molar content of less than 20% of polymeric chains of molecular weight less than 3,000 g/mole. It also concerns the aqueous suspensions obtained, possibly dried, and their uses in the paper, paint, plastics and mastics industry.2011-05-05
20110105671SYNTHETIC CARBIDE LIME FILLER COMPOSITION AND METHOD OF MAKING - A method for making a white synthetic carbide lime filler composition of calcium hydroxide and calcium carbonate, wherein the calcium carbonate is in the form of surface carbonation on the calcium hydroxide. The method can include calcining calcium carbonate, hydrating the calcined material under controlled conditions which maintain a low moisture content and fracture the hydrated material into small particles of calcium hydroxide, carbonating the small calcium hydroxide particles to create the surface carbonation of calcium carbonate, and classifying the carbonated synthetic carbide lime particles to separate off oversized particles. The method can use a combined classifying and carbonating process, and a modified classifying vessel can be provided to carry out the combined process2011-05-05
20110105672ADHESIVES COMPOSITION COMPRISING MIXTURES OF MULTI-BLOCK COPOLYMERS - The present invention relates to an adhesive composition comprising a mixture of multi-block copolymers, in particular, an adhesive composition comprising a block copolymer represented by Formula 1, a hydrocarbon adhesive resin and a plasticizer. The adhesive composition according to the present invention can be easily processed due to its low melting point and shows improved adhesive properties such as loop tack, 180° peel strength and holding power.2011-05-05
20110105673THERMOPLASTIC ALIPHATIC URETHANE/UREA MOLDING COMPOSITIONS - Compositions for forming molded articles, particularly, shells for automotive applications are made up of an aliphatic thermoplastic urethane/urea elastomer and, optionally, one or more copolymers, such as an olefin-containing or styrene containing copolymer. These compositions may be used to form a powder, pellets, microspheres or minibeads which may then be cast to form air bag door and instrument panel cover skins which may meet automotive deployment and weathering requirements.2011-05-05
20110105674METHOD FOR PROVIDING TOUGHENED POLY(TRIMETHYLENE TEREPHTHALATE) MOLDING RESINS - Disclosed is a method including (A) melt blending first components including (a-1) a poly(trimethylene terephthalate) homopolymer or copolymer resin; and (a-2) one or more ionomer polymers or a combination of one or more ionomer polymers and acid polymers; to provide a first melt blend; and (B) melt blending said first melt blend with one or more Group B polymeric toughener(s) selected from the group consisting of an ethylene copolymers of the formula E/X/Y wherein: 2011-05-05
20110105675POLYOLEFIN-BASED ADHESIVES HAVING IMPROVED OXIDATIVE STABILITY - Disclosed is an adhesive composition. The adhesive composition comprises a polyolefin, a maleated polyolefin, a Bronsted acid, and an antioxidant. The adhesive composition has improved oxidative stability compared with those which do not contain Bronsted acids.2011-05-05
20110105676PROCESS FOR PREPARING PLATELET-LIKE PIGMENTS COMPRISING A NITROGEN DOPED CARBON COATING - The invention relates to a process for preparing platelet-like pigments comprising a core and at least one coating layer consisting essentially of a compound having from 60 to 95% by weight of carbon and from 5 to 25% by weight of nitrogen, the balance to 100% being selected from elements of the group consisting of hydrogen, oxygen and sulfur, comprising the steps of: (a) suspending plateletlike particles in a liquid; (b) adding one or more polymers containing nitrogen and carbon atoms, or (a1) suspending one or more polymers containing nitrogen and carbon atoms in a liquid; (b1) adding the plateletlike particles, (c) effecting a polymeric coating layer to be formed on the surface of said plateletlike particles from the polymers added at step (b), or (a1); (d) isolating said plateletlike particles having said polymeric coating layer from the suspension; and (e) heating said plateletlike particles having said polymeric coating layer to a temperature of from 100° C. to 1000° C. in a gaseous environment, to the pigments obtained by the method and the use thereof. It is possible by the process of the present invention to obtain very regular, homogeneous and continuous coatings in an extremely wide range of thicknesses.2011-05-05
20110105677Light-Scattering Compositions - Light-scattering compositions comprising diffuser polymer particles are disclosed. Also disclosed are methods of making and using the light-scattering compositions.2011-05-05
20110105678POLYMER, AND COMPOSITION AND FILM INCLUDING THE SAME - A polymer including a structure represented by the following Chemical Formula 1, and a composition and a film including the same are provided.2011-05-05
20110105679VEHICLE SEAT WITH IMPROVED CRAFTSMANSHIP - A process for improving vehicle seat craftsmanship by camouflaging a receiving surface on a predetermined vehicle component (e.g., a foam seat cushion) is described. The camouflaging conceals the vehicle component from observation. One example of the process includes designating a receiving surface area on the vehicle component and providing a covering material having an opaque characteristic. The covering material includes an opaque dye that bonds with the polyurethane foam that is poured into a mold with deionized water for solidification. Another example of the process further includes spraying the covering material according to a surface of the mold cavity which corresponds to the designated receiving surface area on the vehicle component.2011-05-05
20110105680Polymerizable Composition - The present invention relates to a polymerizable composition comprising, as a component A, at least one silicon-organic compound having at least two ≡Si—H groups that are reactive in the hydrosilylation reaction and, as a component B, at least one benzoxazine compound having at least two unsaturated carbon-carbon bonds that are reactive in the hydrosilylation reaction with the component A. Additional objects of the present invention include adhesives, sealants or coatings containing the polymerizable composition according to the invention, and the polymerization products of said components.2011-05-05
20110105681ETHYLENE COPOLYMER COMPOSITION, SHEET FOR SEALING A SOLAR CELL ELEMENT, AND SOLAR CELL MODULE - An ethylene copolymer composition which includes a zinc ionomer containing, as a main component, a copolymer having a constituent unit derived from ethylene and a constituent unit derived from (meth)acrylic acid, and a dialkoxysilane having an amino group, is provided. This makes it possible to increase the stability during sheet production. It is preferable that the content ratio of the dialkoxysilane is 15 parts by mass or less based on 100 parts by mass of the zinc ionomer.2011-05-05
20110105682HEAT ADHERENT POLYURETHANE FILM - The object of the present invention is to provide a polyurethane film having heat adhesion and further having high stress retention and excellent elastic functions, and the polyurethane film of the present invention is a heat adherent polyurethane film wherein the thermal adhesion peeling stress indicated by a maximum stress when separating a film from a cotton fabric after hot-pressing the film to the cotton fabric at a temperature of 130° C. under a pressure of 4 bar for 25 seconds is 5.88 N/cm or more and the stress retention at an elongation percentage of 200% indicated by a ratio of a stress (f2011-05-05
20110105683POLYAMIDE RESIN, COMPOSITION CONTAINING THE POLYAMIDE RESIN, AND MOLDED ARTICLES OF THE POLYAMIDE RESIN AND THE COMPOSITION - Disclosed is a polyamide resin which is produced by the polycondensation of (A) pentamethylenediamin, (B) terephthalic acid and/or a derivative thereof, and (C) at least one member selected from adipic acid, sebacic acid, undecanedioic acid, dodecanedioic acid, isophthalic acid, 1,9-diaminononane, 1,10-diaminodecane, 1,12-diaminododecane, caprolactam, undecalactam, laurolactam, aminocaproic acid, 11-aminoundecanoic acid, 12-aminododecanoic acid, and derivatives of these compounds. In the polyamide resin, the ratio of a repeating unit derived from the component (C) is 10 to 50 wt % (inclusive) relative to the total weight of the polymer. A solution of the polyamide resin in 98% sulfuric acid, which contains the polyamide resin at a concentration of 0.01 g/ml, has a relative viscosity of 1.5 to 4.5 at 25° C.2011-05-05
20110105684FATTY ACID MODIFIED POLYESTERAMIDE RESIN AND COMPOSITION - The invention relates to a fatty acid modified polyesteramide resin obtained from components comprising: i) at least one α, β- unsaturated diacid; ii) optionally at least one other diacid and/or anhydride; iii) at least one alkanol-amine; and iv) at least one fatty acid and/or fatty acid derivative; wherein the molar ratio of component iii): [component i)+component ii)] is in the range of from 1.2:1.0 to 3.0:1.0; and wherein component iv) is incorporated in the polyesteramide resin in the range of from 18 to 60 wt % based on the total weight of components i) to iv).2011-05-05
20110105685METHOD FOR PRODUCING CARBON FIBER - A method for producing a carbon fiber, comprising a step of dissolving or dispersing [I] a compound containing Co element; [II] a compound containing at least one element selected from the group consisting of Ti, V, Cr, and Mn; and [III] a compound containing at least one element selected from the group consisting of W and Mo in a solvent to obtain a solution or a fluid dispersion, a step of impregnating a particulate carrier with the solution or the fluid dispersion to prepare a catalyst, and a step of bringing a carbon source into contact with the catalyst in a vapor phase.2011-05-05
20110105686Electret and electrostatic induction conversion device - To provide an electret excellent in thermal stability of electric charge, and an electrostatic induction conversion device comprising such an electret.2011-05-05
20110105687CROSSLINKING AGENT, AND CROSSLINKING POLYMER COMPOSITION AND MOLDED PRODUCT FORMED OF THE SAME - The present invention provides a crosslinking agent which is excellent in processing characteristics and crosslinking performance, and is capable of preventing staining of a molded product upon molding in a metal mold which tends to be induced when using the crosslinking agent together with a triallyl isocyanurate. The crosslinking agent of the present invention comprises an isocyanurate derivative represented by the following general formula (I):2011-05-05
Website © 2025 Advameg, Inc.